Given the involvement of galectin-4 in tumor metastasis in the digestive system, the result suggests that inhibitory oligosaccharides based on the T-antigen could selectively block key interactions (Huflejt and Leffler 2004). The gene discussed is LGALS4; the disease is neoplasm.